Literature DB >> 21377278

Accurate analysis of the change in volume, location, and shape of metastatic cervical lymph nodes during radiotherapy.

Seishin Takao1, Shigeru Tadano, Hiroshi Taguchi, Koichi Yasuda, Rikiya Onimaru, Masayori Ishikawa, Gerard Bengua, Ryusuke Suzuki, Hiroki Shirato.   

Abstract

PURPOSE: To establish a method for the accurate acquisition and analysis of the variations in tumor volume, location, and three-dimensional (3D) shape of tumors during radiotherapy in the era of image-guided radiotherapy. METHODS AND MATERIALS: Finite element models of lymph nodes were developed based on computed tomography (CT) images taken before the start of treatment and every week during the treatment period. A surface geometry map with a volumetric scale was adopted and used for the analysis. Six metastatic cervical lymph nodes, 3.5 to 55.1 cm(3) before treatment, in 6 patients with head and neck carcinomas were analyzed in this study. Three fiducial markers implanted in mouthpieces were used for the fusion of CT images. Changes in the location of the lymph nodes were measured on the basis of these fiducial markers.
RESULTS: The surface geometry maps showed convex regions in red and concave regions in blue to ensure that the characteristics of the 3D tumor geometries are simply understood visually. After the irradiation of 66 to 70 Gy in 2 Gy daily doses, the patterns of the colors had not changed significantly, and the maps before and during treatment were strongly correlated (average correlation coefficient was 0.808), suggesting that the tumors shrank uniformly, maintaining the original characteristics of the shapes in all 6 patients. The movement of the gravitational center of the lymph nodes during the treatment period was everywhere less than ±5 mm except in 1 patient, in whom the change reached nearly 10 mm.
CONCLUSIONS: The surface geometry map was useful for an accurate evaluation of the changes in volume and 3D shapes of metastatic lymph nodes. The fusion of the initial and follow-up CT images based on fiducial markers enabled an analysis of changes in the location of the targets. Metastatic cervical lymph nodes in patients were suggested to decrease in size without significant changes in the 3D shape during radiotherapy. The movements of the gravitational center of the lymph nodes were almost all less than ±5 mm.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21377278     DOI: 10.1016/j.ijrobp.2010.11.078

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Forecasting longitudinal changes in oropharyngeal tumor morphology throughout the course of head and neck radiation therapy.

Authors:  Adam D Yock; Arvind Rao; Lei Dong; Beth M Beadle; Adam S Garden; Rajat J Kudchadker; Laurence E Court
Journal:  Med Phys       Date:  2014-08       Impact factor: 4.071

2.  Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.

Authors:  Yukiko Nishikawa; Koichi Yasuda; Shozo Okamoto; Yoichi M Ito; Rikiya Onimaru; Tohru Shiga; Kazuhiko Tsuchiya; Shiro Watanabe; Wataru Takeuchi; Yuji Kuge; Hao Peng; Nagara Tamaki; Hiroki Shirato
Journal:  Radiat Oncol       Date:  2017-09-06       Impact factor: 3.481

3.  Prospective assessment of inter- or intra-fractional variation according to body weight or volume change in patients with head and neck cancer undergoing radiotherapy.

Authors:  Seong Hoon Kim; Se An Oh; Ji Woon Yea; Jae Won Park
Journal:  PLoS One       Date:  2019-05-16       Impact factor: 3.240

4.  Effect of Body Size Change on Off-Center Cervical Point and Face Doses in Patients Undergoing Nasopharyngeal Carcinoma Radiotherapy.

Authors:  Meifang Fang; Lu Xu; Xianxiang Wu; Zhen Cui; Zelai He; Haoxuan Zhang; Hao Jin
Journal:  Dis Markers       Date:  2022-04-25       Impact factor: 3.434

5.  Setup uncertainties for inter-fractional head and neck cancer in radiotherapy.

Authors:  Eun-Tae Park; Sung Kwang Park
Journal:  Oncotarget       Date:  2016-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.